CVS stock forecast
Our latest prediction for CVS Health Corp.'s stock price was made on the Nov. 29, 2018 when the stock price was at 80.00$.
In the short term (2weeks), CVS's stock price should outperform the market by 0.01%. During that period the price should oscillate between -3.46% and +3.27%.
In the medium term (3months), CVS's stock price should underperform the market by -0.02%. During that period the price should oscillate between -7.24% and +9.72%.Get email alerts
Create a solid portfolio with CVS
About CVS Health Corp.
CVS Health Corp. engages in the provision of health care services. It operates through the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits, and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioural health, medical management capabilities. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
At the moment the company generates 261972M USD in revenues.
On its last earning announcement, the company reported a profit of 5.52$ per share.
The book value per share is 34.97$
Three months stock forecastNov. 29, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|